Healthy volunteers 1UIFB2

You may qualify and be compensated up to $2,500 if you meet the following requirements:

• Females and males from 18 to 55 years
• No smokers or smokers (no more than 9 cigarettes per day)
• BMI between 18 and 32 kg/m2
• Good visual acuity (natural or corrected)
• No ocular pathology or surgery
• No medications, including vitamins (except for paracetamol, contraceptives, or Hormone Replacement Therapy)

Study duration: 18 days maximum with 1 screening day, 1 overnight stay, 1 dosing day, and 3 outpatient visits.

Study objective: The study drug (eye drops T4090) is intended to reduce Intra-Ocular Pressure (IOP) in adult patients. This clinical trial will evaluate the study drug’s safety and systemic plasma concentration in healthy participants.

For more information, contact our recruiters at 844-246-8459 or email us at recruitment@biotrial.us

Click here for the study calendars.

What is glaucoma?  Intra-Ocular Pressure (IOP) can damage the optic nerve and lead to glaucoma and vision loss. Glaucoma is one of the leading causes of irreversible blindness on a global scale. In the US, the prevalence of glaucoma is predicted to go from 2.7 million in 2010 to 6.3 million in 2050.